Announcements
- EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
- EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
- EQS-AFR: Sartorius AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
- EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
- EQS-DD: Sartorius AG: Dr. Florian Funck, Transfer of 1207 preference shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
- EQS-DD: Sartorius AG: Dr. Florian Funck, Transfer of 1500 ordinary shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
- EQS-News: Resolutions of the Annual General Meeting of Sartorius AG
More ▼
Key statistics
As of last trade Sartorius AG (SRT4:DUS) traded at 39.40, 3.68% above its 52-week low of 38.00, set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.00 |
---|---|
High | 40.00 |
Low | 39.40 |
Bid | 39.40 |
Offer | 44.00 |
Previous close | 39.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.1471 EUR |
---|---|
Annual div yield (ADY) | 0.37% |
Div ex-date | Apr 02 2024 |
Div pay-date | Apr 18 2024 |
Data delayed at least 15 minutes, as of May 23 2024 15:30 BST.
More ▼